0000000000821623

AUTHOR

M. J. Minkin

showing 2 related works from this author

Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence

2020

A systematic literature search revealed 35 clinical studies and one meta-analysis comprising 43,759 women, of which 13,096 were treated with isopropanolic Cimicifuga racemosa extract (iCR). Compared to placebo, iCR was significantly superior for treating neurovegetative and psychological menopausal symptoms, with a standardized mean difference of 0.694 in favor of iCR (p<0.0001). Effect sizes were larger when higher dosages of iCR as monotherapy or in combination with St. John's wort (Hypericum perforatum [HP]) were given ( 1.020 and 0.999, respectively), suggesting a dose-depend- ency. For psychological symptoms, the iCRþHP combination was superior to iCR monotherapy. Efficacy of iCR was c…

Cimicifugaanimal diseasesBlack cohosh030209 endocrinology & metabolismRessenyes sistemàtiques (Investigació mèdica)2-Propanol03 medical and health sciences0302 clinical medicineActaea racemosaSystematic reviews (Medical research)HumansMedicineFitoteràpia030219 obstetrics & reproductive medicinebiologyTraditional medicinePlant Extractsbusiness.industryCimicifuga racemosaObstetrics and Gynecologyvirus diseasesGeneral MedicineMiddle Agedbiology.organism_classificationTreatment OutcomeBlack Cohosh ExtractMeta-analysisHot FlashesFemaleMenopausebusinessCimicifuga racemosa extractSystematic searchMenopausaPhytotherapy
researchProduct

Review &amp; meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence

2020

A systematic literature search revealed 35 clinical studies and one meta-analysis comprising 43,759 women, of which 13,096 were treated with isopropanolic Cimicifuga racemosa extract (iCR). Compared to placebo, iCR was significantly superior for treating neurovegetative and psychological menopausal symptoms, with a standardized mean difference of −0.694 in favor of iCR (p Hypericum perforatum [HP]) were given (−1.020 and −0.999, respectively), suggesting a dose-dependency. For psychological symptoms, the iCR+HP combination was superior to iCR monotherapy. Efficacy of iCR was comparable to low-dose transdermal estradiol or tibolone. Yet, due to its better tolerability, iCR had a significantl…

animal diseasesvirus diseases
researchProduct